- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Early catheter ablation for AF after HF hospitalistation may improve long-term outcomes
Early catheter ablation (CA) for atrial fibrillation (AF) in patients with heart failure (HF) has shown promising results in improving long-term outcomes, according to a new study published in JACC Clinical Electrophysiology by Kazuo Sakamoto and colleagues based on data from the Japanese Registry of Acute Decompensated Heart Failure (JROADHF). The study investigated the impact of early CA, performed within 90 days after admission for worsening HF, on patient prognosis.
Researchers identified 103 patients who underwent early CA and compared them to a control group of 2,683 patients with HF and AF who did not undergo CA within the same timeframe.
● The study found that in the crude cohort, all-cause mortality was significantly lower in the early CA group compared to the control group (log-rank P < 0.001; HR: 0.38; 95% CI: 0.24-0.60).
● After conducting a propensity-matched analysis, which included 83 patients in each group, the results remained consistent, with all-cause mortality being significantly lower in the early CA group (log-rank P = 0.014; HR: 0.47; 95% CI: 0.25-0.88).
● The study showed that cardiovascular death and HF mortality were significantly lower in both cohorts.
● In the crude cohort, cardiovascular death (Gray's test: P < 0.001) and HF mortality (Gray's test: P = 0.005) were markedly reduced, with subdistribution HRs of 0.28 (95% CI: 0.13-0.63) and 0.31 (95% CI: 0.13-0.75), respectively.
● In the matched cohort, cardiovascular death (Gray's test: P = 0.006) and HF mortality (Gray's test: P = 0.017) were significantly lower, with subdistribution HRs of 0.24 (95% CI: 0.08-0.70) and 0.28 (95% CI: 0.09-0.84), respectively.
These findings suggest that early CA for AF in patients with HF can lead to improved long-term outcomes, reducing the risk of cardiovascular and HF-related deaths. The study provides valuable insights into the potential benefits of early CA in this patient population, paving the way for further research and optimized treatment strategies for HF patients with AF.
Reference:
Sakamoto, K., Tohyama, T., Ide, T., Mukai, Y., Enzan, N., Nagata, T., Ikeda, M., Takase, S., Nagayama, T., Fujino, T., Matsushima, S., & Tsutsui, H. (2023). Efficacy of early catheter ablation for atrial fibrillation after admission for heart failure. JACC. Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2023.05.038
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751